048410.KQ

Hyundai Bioscience Co., Ltd. [048410.KQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

048410.KQ Stock Summary

Top 10 Correlated ETFs

048410.KQ


Top 10 Correlated Stocks

048410.KQ


In the News

048410.KQ Financial details

Company Rating
Sell
Market Cap
909.78B
Income
-14.5B
Revenue
9.48B
Book val./share
1137.24
Cash/share
296.72
Dividend
-
Dividend %
-
Employees
63
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-52.97
Forward P/E
-
PEG
57.28
P/S
92.98
P/B
17.43
P/C
72.46
P/FCF
-85.33
Quick Ratio
2.17
Current Ratio
2.59
Debt / Equity
0.12
LT Debt / Equity
-
-
-
EPS (TTM)
-364.4
EPS next Y
-
EPS next Q
-
EPS this Y
-9.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-20.62%
Revenue Q/Q
-42.25%
EPS Q/Q
308.55%
-
-
-
-
SMA20
0.57%
SMA50
-11.87%
SMA100
-42.86%
Inst Own
-
Inst Trans
-
ROA
-29%
ROE
-31%
ROC
-0.32%
Gross Margin
53%
Oper. Margin
-170%
Profit Margin
-175%
Payout
-
Shs Outstand
39.82M
Shs Float
34.71M
-
-
-
-
Target Price
-
52W Range
17600.0-41200.0
52W High
-47.82%
52W Low
+22.16%
RSI
52.31
Rel Volume
1.16
Avg Volume
436.13K
Volume
506.81K
Perf Week
2.38%
Perf Month
-0.23%
Perf Quarter
-23.08%
Perf Half Y
-22.24%
-
-
-
-
Beta
1.193
-
-
Volatility
655.12%, 936.15%
Prev Close
2.38%
Price
21500
Change
0.7%

048410.KQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
868.45348.38250.34199.44238.37
Net income per share
22.15-229.99-543.16-401.53-364.53
Operating cash flow per share
256.83201.67-20.27-425.88-158.32
Free cash flow per share
-120.31-500.12-122.17-465.09-173.1
Cash per share
203.65535.04601.35475.84296.96
Book value per share
1.36K1.46K1.67K1.48K1.14K
Tangible book value per share
795.19360.39755.94636.591.14K
Share holders equity per share
1.36K1.46K1.67K1.48K1.14K
Interest debt per share
409.741.05K496.15169.07146.54
Market cap
486.74B1048.68B932.12B1066.86B1042.13B
Enterprise value
494.69B1066.6B938.42B1070.38B1045.87B
P/E ratio
634.42-126.96-46.49-67.49-71.87
Price to sales ratio
16.1883.82100.86135.88109.91
POCF ratio
54.71144.79-1.25K-63.63-165.48
PFCF ratio
-116.78-58.39-206.68-58.27-151.36
P/B Ratio
10.3720.0415.1418.3223.02
PTB ratio
10.3720.0415.1418.3223.02
EV to sales
16.4485.25101.54136.33110.31
Enterprise value over EBITDA
79.37-1.64K-142.49-43.64-124.97
EV to operating cash flow
55.6147.26-1.25K-63.84-166.08
EV to free cash flow
-118.69-59.38-208.07-58.46-151.9
Earnings yield
0-0.01-0.02-0.01-0.01
Free cash flow yield
-0.01-0.020-0.02-0.01
Debt to equity
0.290.70.250.110.12
Debt to assets
0.210.390.190.090.1
Net debt to EBITDA
1.28-27.48-0.96-0.14-0.45
Current ratio
2.394.672.092.862.18
Interest coverage
3.13-3.92-3.09-58.64-31.17
Income quality
7.32-0.880.041.060.43
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
000.0100
Research and developement to revenue
0.040.130.482.10.61
Intangibles to total assets
0.310.420.420.490
Capex to operating cash flow
-1.47-3.485.030.090.09
Capex to revenue
-0.43-2.01-0.41-0.2-0.06
Capex to depreciation
-3.43-6.67-1.39-0.87-0.41
Stock based compensation to revenue
00000
Graham number
821.822.75K4.51K3.66K3.06K
ROIC
0.04-0.05-0.12-0.39-0.19
Return on tangible assets
0.02-0.15-0.43-0.46-0.27
Graham Net
251.37-198.6314.27315.47150.84
Working capital
19.32B32.89B18.2B15.63B8.22B
Tangible asset value
27.55B12.94B27.91B25.06B45.27B
Net current asset value
16.99B456.54M15.89B14.92B7.64B
Invested capital
0.290.70.250.110.12
Average receivables
20.99B18.56B13.09B5.33B1.15B
Average payables
608.64M502.96M184.89M439.16M558.62M
Average inventory
5.13B5.15B3.78B3.15B2.77B
Days sales outstanding
240.89503.66352.0280.921.28
Days payables outstanding
16.227.229.0642.4428.26
Days of inventory on hand
119.12170.86158.47182.1169.92
Receivables turnover
1.520.721.044.5117.15
Payables turnover
22.5150.5340.278.612.91
Inventory turnover
3.062.142.322.15
ROE
0.02-0.16-0.33-0.27-0.32
Capex per share
-377.14-701.8-101.91-39.21-14.77

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
44.3279.6680.9749.3228.48
Net income per share
-288.33-52.82-58.73-49.72-203.13
Operating cash flow per share
-139.5-59.94-14.71-52.44-31.28
Free cash flow per share
-146.91-72.71-15.3-53.11-32.05
Cash per share
484.57414.63391.8336.7296.72
Book value per share
1.51K1.44K1.39K1.34K1.14K
Tangible book value per share
648.28601.91557.58513.181.14K
Share holders equity per share
1.51K1.44K1.39K1.34K1.14K
Interest debt per share
162.61155.87141.56147.54140.04
Market cap
1047.62B819.72B1058.55B1170.24B1042.96B
Enterprise value
1051.13B822.43B1059.59B1172.83B1046.7B
P/E ratio
-23.5-97.73-113.23-147.83-32.25
Price to sales ratio
611.48259.21328.52596.11919.96
POCF ratio
-194.27-344.5-1.81K-560.61-837.73
PFCF ratio
-184.47-283.99-1.74K-553.61-817.41
P/B Ratio
17.9914.3819.1821.9323.04
PTB ratio
17.9914.3819.1821.9323.04
EV to sales
613.53260.07328.84597.43923.26
Enterprise value over EBITDA
-100.57-441.77-679.98-703.03-319.06
EV to operating cash flow
-194.92-345.64-1.81K-561.85-840.73
EV to free cash flow
-185.09-284.93-1.74K-554.83-820.34
Earnings yield
-0.01000-0.01
Free cash flow yield
-0.010000
Debt to equity
0.110.110.10.110.12
Debt to assets
0.090.090.090.090.1
Net debt to EBITDA
-0.34-1.46-0.67-1.55-1.14
Current ratio
2.862.832.952.592.18
Interest coverage
-137.28-30.08-25.54-20.1-58.04
Income quality
0.481.130.251.050.15
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
2.630.660.420.61.05
Intangibles to total assets
0.490.50.530.540
Capex to operating cash flow
0.050.210.040.010.02
Capex to revenue
-0.17-0.16-0.01-0.01-0.03
Capex to depreciation
-0.73-1.17-0.06-0.08-0.13
Stock based compensation to revenue
00000
Graham number
3.13K1.31K1.35K1.22K2.28K
ROIC
-0.17-0.04-0.03-0.03-0.07
Return on tangible assets
-0.33-0.06-0.08-0.07-0.15
Graham Net
321.27288.33284.9228.75150.72
Working capital
15.63B14.37B13.16B11.43B8.22B
Tangible asset value
25.06B23.89B22.19B20.43B45.27B
Net current asset value
14.92B13.61B13B11.16B7.64B
Invested capital
0.110.110.10.110.12
Average receivables
5.13B2.37B2.59B2.45B1.64B
Average payables
759.23M675.99M576.48M567.83M539.25M
Average inventory
2.62B2.84B2.38B2.16B2.43B
Days sales outstanding
91.4285.160.93124.7443.88
Days payables outstanding
47.2134.8525.4448.8642.01
Days of inventory on hand
202.55143.05106.28171.84252.54
Receivables turnover
0.981.061.480.722.05
Payables turnover
1.912.583.541.842.14
Inventory turnover
0.440.630.850.520.36
ROE
-0.19-0.04-0.04-0.04-0.18
Capex per share
-7.41-12.77-0.58-0.66-0.78

048410.KQ Frequently Asked Questions

What is Hyundai Bioscience Co., Ltd. stock symbol ?

Hyundai Bioscience Co., Ltd. is a KR stock and trading under the symbol 048410.KQ

What is Hyundai Bioscience Co., Ltd. stock quote today ?

Hyundai Bioscience Co., Ltd. stock price is $21500 today.

Is Hyundai Bioscience Co., Ltd. stock public?

Yes, Hyundai Bioscience Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs